Quarter
Charts

Aclaris Therapeutics, Inc.

ACRS

CIK 0001557746 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1M
↓-85.9% -$8Mvs FY2024 (Q4)
Gross Profit
$763K
↓-91.0% -$8Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
31/100
  • Profitability
    0ROIC -46.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 3.36 (above 1.5 = solid)
  • Leverage
    86D/E 0.28 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.04x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -85.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -519.8% · trend -434.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$111K
investment in PP&E
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$160M
everything owned
Total liabilities
$57M
everything owed
Stockholders' equity
$103M
shareholder claim
Net debt
$-9M
Net cash position ($9M)

Recent performance · 51 quarters

Revenue↓-85.9% -$8M
$1M
Net Income↓-92.6% -$7M
$-15M
Free Cash Flow
$-24K
Operating Margin↓-278.9pts
-519.8%

Drill down

ACRS Sankey

See Aclaris Therapeutics, Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

ACRS Charts

51 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

ACRS Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics